Global Next-Generation Drug-Eluting Stent Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Next-Generation Drug-Eluting Stent market size was valued at US$ million in 2023. With growing demand in downstream market, the Next-Generation Drug-Eluting Stent is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Next-Generation Drug-Eluting Stent market. Next-Generation Drug-Eluting Stent are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Next-Generation Drug-Eluting Stent. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Next-Generation Drug-Eluting Stent market.
Next-generation drug-eluting stent is advantageous as it offers improved deliverability by using materials like cobalt chromium, cobalt nickel, and cobalt alloy, this results in significant reduction in strut width, and enhance stent flexibility. In next-generation drug eluting stent, several drugs are coated in stents to address multiple restenosis pathways by altering drug release kinetics that mimics restenosis cascade. In addition, next-generation drug-eluting stent utilizes bioabsorbable polymers to reduce complications of late stent thrombosis, and bioresorbable drug-eluting scaffold plays a vital role in transforming coronary artery disease treatment.
The market in North America is anticipated to show the largest market share for the next-generation drug-eluting stent, followed by Europe, owing to the high prevalence and incidence of coronary artery disease. In addition, presence sophisticated healthcare infrastructure, and well-trained healthcare professionals are also impelling the growth of next-generation drug eluting stent market. The market in Asia-Pacific region is estimated to grow at fastest CAGR over the forecast period owing to increasing investment from both public and private bodies and improving healthcare facilities. However, market in the Middle East & Africa shows the steady growth during the forecast period.
Key Features:
The report on Next-Generation Drug-Eluting Stent market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Next-Generation Drug-Eluting Stent market. It may include historical data, market segmentation by Type (e.g., Cobalt Chromium, Stainless Steel), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Next-Generation Drug-Eluting Stent market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Next-Generation Drug-Eluting Stent market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Next-Generation Drug-Eluting Stent industry. This include advancements in Next-Generation Drug-Eluting Stent technology, Next-Generation Drug-Eluting Stent new entrants, Next-Generation Drug-Eluting Stent new investment, and other innovations that are shaping the future of Next-Generation Drug-Eluting Stent.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Next-Generation Drug-Eluting Stent market. It includes factors influencing customer ' purchasing decisions, preferences for Next-Generation Drug-Eluting Stent product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Next-Generation Drug-Eluting Stent market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Next-Generation Drug-Eluting Stent market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Next-Generation Drug-Eluting Stent market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Next-Generation Drug-Eluting Stent industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Next-Generation Drug-Eluting Stent market.
Market Segmentation:
Next-Generation Drug-Eluting Stent market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Next-Generation Drug-Eluting Stent market?
What factors are driving Next-Generation Drug-Eluting Stent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Next-Generation Drug-Eluting Stent market opportunities vary by end market size?
How does Next-Generation Drug-Eluting Stent break out type, application?
According to our LPI (LP Information) latest study, the global Next-Generation Drug-Eluting Stent market size was valued at US$ million in 2023. With growing demand in downstream market, the Next-Generation Drug-Eluting Stent is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Next-Generation Drug-Eluting Stent market. Next-Generation Drug-Eluting Stent are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Next-Generation Drug-Eluting Stent. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Next-Generation Drug-Eluting Stent market.
Next-generation drug-eluting stent is advantageous as it offers improved deliverability by using materials like cobalt chromium, cobalt nickel, and cobalt alloy, this results in significant reduction in strut width, and enhance stent flexibility. In next-generation drug eluting stent, several drugs are coated in stents to address multiple restenosis pathways by altering drug release kinetics that mimics restenosis cascade. In addition, next-generation drug-eluting stent utilizes bioabsorbable polymers to reduce complications of late stent thrombosis, and bioresorbable drug-eluting scaffold plays a vital role in transforming coronary artery disease treatment.
The market in North America is anticipated to show the largest market share for the next-generation drug-eluting stent, followed by Europe, owing to the high prevalence and incidence of coronary artery disease. In addition, presence sophisticated healthcare infrastructure, and well-trained healthcare professionals are also impelling the growth of next-generation drug eluting stent market. The market in Asia-Pacific region is estimated to grow at fastest CAGR over the forecast period owing to increasing investment from both public and private bodies and improving healthcare facilities. However, market in the Middle East & Africa shows the steady growth during the forecast period.
Key Features:
The report on Next-Generation Drug-Eluting Stent market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Next-Generation Drug-Eluting Stent market. It may include historical data, market segmentation by Type (e.g., Cobalt Chromium, Stainless Steel), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Next-Generation Drug-Eluting Stent market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Next-Generation Drug-Eluting Stent market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Next-Generation Drug-Eluting Stent industry. This include advancements in Next-Generation Drug-Eluting Stent technology, Next-Generation Drug-Eluting Stent new entrants, Next-Generation Drug-Eluting Stent new investment, and other innovations that are shaping the future of Next-Generation Drug-Eluting Stent.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Next-Generation Drug-Eluting Stent market. It includes factors influencing customer ' purchasing decisions, preferences for Next-Generation Drug-Eluting Stent product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Next-Generation Drug-Eluting Stent market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Next-Generation Drug-Eluting Stent market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Next-Generation Drug-Eluting Stent market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Next-Generation Drug-Eluting Stent industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Next-Generation Drug-Eluting Stent market.
Market Segmentation:
Next-Generation Drug-Eluting Stent market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Cobalt Chromium
- Stainless Steel
- Others
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- Biosensors International
- Medtronic
- Sorin Group
- SMT
- Terumo
What is the 10-year outlook for the global Next-Generation Drug-Eluting Stent market?
What factors are driving Next-Generation Drug-Eluting Stent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Next-Generation Drug-Eluting Stent market opportunities vary by end market size?
How does Next-Generation Drug-Eluting Stent break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Next-Generation Drug-Eluting Stent Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Next-Generation Drug-Eluting Stent by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Next-Generation Drug-Eluting Stent by Country/Region, 2019, 2023 & 2030
2.2 Next-Generation Drug-Eluting Stent Segment by Type
2.2.1 Cobalt Chromium
2.2.2 Stainless Steel
2.2.3 Others
2.3 Next-Generation Drug-Eluting Stent Sales by Type
2.3.1 Global Next-Generation Drug-Eluting Stent Sales Market Share by Type (2019-2024)
2.3.2 Global Next-Generation Drug-Eluting Stent Revenue and Market Share by Type (2019-2024)
2.3.3 Global Next-Generation Drug-Eluting Stent Sale Price by Type (2019-2024)
2.4 Next-Generation Drug-Eluting Stent Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.5 Next-Generation Drug-Eluting Stent Sales by Application
2.5.1 Global Next-Generation Drug-Eluting Stent Sale Market Share by Application (2019-2024)
2.5.2 Global Next-Generation Drug-Eluting Stent Revenue and Market Share by Application (2019-2024)
2.5.3 Global Next-Generation Drug-Eluting Stent Sale Price by Application (2019-2024)
3 GLOBAL NEXT-GENERATION DRUG-ELUTING STENT BY COMPANY
3.1 Global Next-Generation Drug-Eluting Stent Breakdown Data by Company
3.1.1 Global Next-Generation Drug-Eluting Stent Annual Sales by Company (2019-2024)
3.1.2 Global Next-Generation Drug-Eluting Stent Sales Market Share by Company (2019-2024)
3.2 Global Next-Generation Drug-Eluting Stent Annual Revenue by Company (2019-2024)
3.2.1 Global Next-Generation Drug-Eluting Stent Revenue by Company (2019-2024)
3.2.2 Global Next-Generation Drug-Eluting Stent Revenue Market Share by Company (2019-2024)
3.3 Global Next-Generation Drug-Eluting Stent Sale Price by Company
3.4 Key Manufacturers Next-Generation Drug-Eluting Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Next-Generation Drug-Eluting Stent Product Location Distribution
3.4.2 Players Next-Generation Drug-Eluting Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEXT-GENERATION DRUG-ELUTING STENT BY GEOGRAPHIC REGION
4.1 World Historic Next-Generation Drug-Eluting Stent Market Size by Geographic Region (2019-2024)
4.1.1 Global Next-Generation Drug-Eluting Stent Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Next-Generation Drug-Eluting Stent Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Next-Generation Drug-Eluting Stent Market Size by Country/Region (2019-2024)
4.2.1 Global Next-Generation Drug-Eluting Stent Annual Sales by Country/Region (2019-2024)
4.2.2 Global Next-Generation Drug-Eluting Stent Annual Revenue by Country/Region (2019-2024)
4.3 Americas Next-Generation Drug-Eluting Stent Sales Growth
4.4 APAC Next-Generation Drug-Eluting Stent Sales Growth
4.5 Europe Next-Generation Drug-Eluting Stent Sales Growth
4.6 Middle East & Africa Next-Generation Drug-Eluting Stent Sales Growth
5 AMERICAS
5.1 Americas Next-Generation Drug-Eluting Stent Sales by Country
5.1.1 Americas Next-Generation Drug-Eluting Stent Sales by Country (2019-2024)
5.1.2 Americas Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024)
5.2 Americas Next-Generation Drug-Eluting Stent Sales by Type
5.3 Americas Next-Generation Drug-Eluting Stent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Next-Generation Drug-Eluting Stent Sales by Region
6.1.1 APAC Next-Generation Drug-Eluting Stent Sales by Region (2019-2024)
6.1.2 APAC Next-Generation Drug-Eluting Stent Revenue by Region (2019-2024)
6.2 APAC Next-Generation Drug-Eluting Stent Sales by Type
6.3 APAC Next-Generation Drug-Eluting Stent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Next-Generation Drug-Eluting Stent by Country
7.1.1 Europe Next-Generation Drug-Eluting Stent Sales by Country (2019-2024)
7.1.2 Europe Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024)
7.2 Europe Next-Generation Drug-Eluting Stent Sales by Type
7.3 Europe Next-Generation Drug-Eluting Stent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Next-Generation Drug-Eluting Stent by Country
8.1.1 Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Country (2019-2024)
8.1.2 Middle East & Africa Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024)
8.2 Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Type
8.3 Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Next-Generation Drug-Eluting Stent
10.3 Manufacturing Process Analysis of Next-Generation Drug-Eluting Stent
10.4 Industry Chain Structure of Next-Generation Drug-Eluting Stent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Next-Generation Drug-Eluting Stent Distributors
11.3 Next-Generation Drug-Eluting Stent Customer
12 WORLD FORECAST REVIEW FOR NEXT-GENERATION DRUG-ELUTING STENT BY GEOGRAPHIC REGION
12.1 Global Next-Generation Drug-Eluting Stent Market Size Forecast by Region
12.1.1 Global Next-Generation Drug-Eluting Stent Forecast by Region (2025-2030)
12.1.2 Global Next-Generation Drug-Eluting Stent Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Next-Generation Drug-Eluting Stent Forecast by Type
12.7 Global Next-Generation Drug-Eluting Stent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
13.1.3 Abbott Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Biosensors International
13.2.1 Biosensors International Company Information
13.2.2 Biosensors International Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
13.2.3 Biosensors International Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Biosensors International Main Business Overview
13.2.5 Biosensors International Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
13.3.3 Medtronic Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Sorin Group
13.4.1 Sorin Group Company Information
13.4.2 Sorin Group Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
13.4.3 Sorin Group Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sorin Group Main Business Overview
13.4.5 Sorin Group Latest Developments
13.5 SMT
13.5.1 SMT Company Information
13.5.2 SMT Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
13.5.3 SMT Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 SMT Main Business Overview
13.5.5 SMT Latest Developments
13.6 Terumo
13.6.1 Terumo Company Information
13.6.2 Terumo Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
13.6.3 Terumo Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Terumo Main Business Overview
13.6.5 Terumo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Next-Generation Drug-Eluting Stent Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Next-Generation Drug-Eluting Stent by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Next-Generation Drug-Eluting Stent by Country/Region, 2019, 2023 & 2030
2.2 Next-Generation Drug-Eluting Stent Segment by Type
2.2.1 Cobalt Chromium
2.2.2 Stainless Steel
2.2.3 Others
2.3 Next-Generation Drug-Eluting Stent Sales by Type
2.3.1 Global Next-Generation Drug-Eluting Stent Sales Market Share by Type (2019-2024)
2.3.2 Global Next-Generation Drug-Eluting Stent Revenue and Market Share by Type (2019-2024)
2.3.3 Global Next-Generation Drug-Eluting Stent Sale Price by Type (2019-2024)
2.4 Next-Generation Drug-Eluting Stent Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.5 Next-Generation Drug-Eluting Stent Sales by Application
2.5.1 Global Next-Generation Drug-Eluting Stent Sale Market Share by Application (2019-2024)
2.5.2 Global Next-Generation Drug-Eluting Stent Revenue and Market Share by Application (2019-2024)
2.5.3 Global Next-Generation Drug-Eluting Stent Sale Price by Application (2019-2024)
3 GLOBAL NEXT-GENERATION DRUG-ELUTING STENT BY COMPANY
3.1 Global Next-Generation Drug-Eluting Stent Breakdown Data by Company
3.1.1 Global Next-Generation Drug-Eluting Stent Annual Sales by Company (2019-2024)
3.1.2 Global Next-Generation Drug-Eluting Stent Sales Market Share by Company (2019-2024)
3.2 Global Next-Generation Drug-Eluting Stent Annual Revenue by Company (2019-2024)
3.2.1 Global Next-Generation Drug-Eluting Stent Revenue by Company (2019-2024)
3.2.2 Global Next-Generation Drug-Eluting Stent Revenue Market Share by Company (2019-2024)
3.3 Global Next-Generation Drug-Eluting Stent Sale Price by Company
3.4 Key Manufacturers Next-Generation Drug-Eluting Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Next-Generation Drug-Eluting Stent Product Location Distribution
3.4.2 Players Next-Generation Drug-Eluting Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEXT-GENERATION DRUG-ELUTING STENT BY GEOGRAPHIC REGION
4.1 World Historic Next-Generation Drug-Eluting Stent Market Size by Geographic Region (2019-2024)
4.1.1 Global Next-Generation Drug-Eluting Stent Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Next-Generation Drug-Eluting Stent Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Next-Generation Drug-Eluting Stent Market Size by Country/Region (2019-2024)
4.2.1 Global Next-Generation Drug-Eluting Stent Annual Sales by Country/Region (2019-2024)
4.2.2 Global Next-Generation Drug-Eluting Stent Annual Revenue by Country/Region (2019-2024)
4.3 Americas Next-Generation Drug-Eluting Stent Sales Growth
4.4 APAC Next-Generation Drug-Eluting Stent Sales Growth
4.5 Europe Next-Generation Drug-Eluting Stent Sales Growth
4.6 Middle East & Africa Next-Generation Drug-Eluting Stent Sales Growth
5 AMERICAS
5.1 Americas Next-Generation Drug-Eluting Stent Sales by Country
5.1.1 Americas Next-Generation Drug-Eluting Stent Sales by Country (2019-2024)
5.1.2 Americas Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024)
5.2 Americas Next-Generation Drug-Eluting Stent Sales by Type
5.3 Americas Next-Generation Drug-Eluting Stent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Next-Generation Drug-Eluting Stent Sales by Region
6.1.1 APAC Next-Generation Drug-Eluting Stent Sales by Region (2019-2024)
6.1.2 APAC Next-Generation Drug-Eluting Stent Revenue by Region (2019-2024)
6.2 APAC Next-Generation Drug-Eluting Stent Sales by Type
6.3 APAC Next-Generation Drug-Eluting Stent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Next-Generation Drug-Eluting Stent by Country
7.1.1 Europe Next-Generation Drug-Eluting Stent Sales by Country (2019-2024)
7.1.2 Europe Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024)
7.2 Europe Next-Generation Drug-Eluting Stent Sales by Type
7.3 Europe Next-Generation Drug-Eluting Stent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Next-Generation Drug-Eluting Stent by Country
8.1.1 Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Country (2019-2024)
8.1.2 Middle East & Africa Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024)
8.2 Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Type
8.3 Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Next-Generation Drug-Eluting Stent
10.3 Manufacturing Process Analysis of Next-Generation Drug-Eluting Stent
10.4 Industry Chain Structure of Next-Generation Drug-Eluting Stent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Next-Generation Drug-Eluting Stent Distributors
11.3 Next-Generation Drug-Eluting Stent Customer
12 WORLD FORECAST REVIEW FOR NEXT-GENERATION DRUG-ELUTING STENT BY GEOGRAPHIC REGION
12.1 Global Next-Generation Drug-Eluting Stent Market Size Forecast by Region
12.1.1 Global Next-Generation Drug-Eluting Stent Forecast by Region (2025-2030)
12.1.2 Global Next-Generation Drug-Eluting Stent Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Next-Generation Drug-Eluting Stent Forecast by Type
12.7 Global Next-Generation Drug-Eluting Stent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
13.1.3 Abbott Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Biosensors International
13.2.1 Biosensors International Company Information
13.2.2 Biosensors International Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
13.2.3 Biosensors International Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Biosensors International Main Business Overview
13.2.5 Biosensors International Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
13.3.3 Medtronic Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Sorin Group
13.4.1 Sorin Group Company Information
13.4.2 Sorin Group Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
13.4.3 Sorin Group Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sorin Group Main Business Overview
13.4.5 Sorin Group Latest Developments
13.5 SMT
13.5.1 SMT Company Information
13.5.2 SMT Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
13.5.3 SMT Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 SMT Main Business Overview
13.5.5 SMT Latest Developments
13.6 Terumo
13.6.1 Terumo Company Information
13.6.2 Terumo Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
13.6.3 Terumo Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Terumo Main Business Overview
13.6.5 Terumo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Next-Generation Drug-Eluting Stent Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Next-Generation Drug-Eluting Stent Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Cobalt Chromium
Table 4. Major Players of Stainless Steel
Table 5. Major Players of Others
Table 6. Global Next-Generation Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 7. Global Next-Generation Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Table 8. Global Next-Generation Drug-Eluting Stent Revenue by Type (2019-2024) & ($ million)
Table 9. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2019-2024)
Table 10. Global Next-Generation Drug-Eluting Stent Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Next-Generation Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 12. Global Next-Generation Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Table 13. Global Next-Generation Drug-Eluting Stent Revenue by Application (2019-2024)
Table 14. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2019-2024)
Table 15. Global Next-Generation Drug-Eluting Stent Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Next-Generation Drug-Eluting Stent Sales by Company (2019-2024) & (K Units)
Table 17. Global Next-Generation Drug-Eluting Stent Sales Market Share by Company (2019-2024)
Table 18. Global Next-Generation Drug-Eluting Stent Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Company (2019-2024)
Table 20. Global Next-Generation Drug-Eluting Stent Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Next-Generation Drug-Eluting Stent Producing Area Distribution and Sales Area
Table 22. Players Next-Generation Drug-Eluting Stent Products Offered
Table 23. Next-Generation Drug-Eluting Stent Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Next-Generation Drug-Eluting Stent Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Next-Generation Drug-Eluting Stent Sales Market Share Geographic Region (2019-2024)
Table 28. Global Next-Generation Drug-Eluting Stent Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Next-Generation Drug-Eluting Stent Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Next-Generation Drug-Eluting Stent Sales Market Share by Country/Region (2019-2024)
Table 32. Global Next-Generation Drug-Eluting Stent Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Next-Generation Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 35. Americas Next-Generation Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 36. Americas Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Next-Generation Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 38. Americas Next-Generation Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 39. Americas Next-Generation Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 40. APAC Next-Generation Drug-Eluting Stent Sales by Region (2019-2024) & (K Units)
Table 41. APAC Next-Generation Drug-Eluting Stent Sales Market Share by Region (2019-2024)
Table 42. APAC Next-Generation Drug-Eluting Stent Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Next-Generation Drug-Eluting Stent Revenue Market Share by Region (2019-2024)
Table 44. APAC Next-Generation Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 45. APAC Next-Generation Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 46. Europe Next-Generation Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 47. Europe Next-Generation Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 48. Europe Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Next-Generation Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 50. Europe Next-Generation Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 51. Europe Next-Generation Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Next-Generation Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Next-Generation Drug-Eluting Stent
Table 59. Key Market Challenges & Risks of Next-Generation Drug-Eluting Stent
Table 60. Key Industry Trends of Next-Generation Drug-Eluting Stent
Table 61. Next-Generation Drug-Eluting Stent Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Next-Generation Drug-Eluting Stent Distributors List
Table 64. Next-Generation Drug-Eluting Stent Customer List
Table 65. Global Next-Generation Drug-Eluting Stent Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Next-Generation Drug-Eluting Stent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Next-Generation Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Next-Generation Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Next-Generation Drug-Eluting Stent Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Next-Generation Drug-Eluting Stent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Next-Generation Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Next-Generation Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Next-Generation Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Next-Generation Drug-Eluting Stent Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Next-Generation Drug-Eluting Stent Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Next-Generation Drug-Eluting Stent Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Next-Generation Drug-Eluting Stent Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Abbott Basic Information, Next-Generation Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 80. Abbott Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
Table 81. Abbott Next-Generation Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Abbott Main Business
Table 83. Abbott Latest Developments
Table 84. Biosensors International Basic Information, Next-Generation Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 85. Biosensors International Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
Table 86. Biosensors International Next-Generation Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Biosensors International Main Business
Table 88. Biosensors International Latest Developments
Table 89. Medtronic Basic Information, Next-Generation Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 90. Medtronic Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
Table 91. Medtronic Next-Generation Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Medtronic Main Business
Table 93. Medtronic Latest Developments
Table 94. Sorin Group Basic Information, Next-Generation Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 95. Sorin Group Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
Table 96. Sorin Group Next-Generation Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Sorin Group Main Business
Table 98. Sorin Group Latest Developments
Table 99. SMT Basic Information, Next-Generation Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 100. SMT Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
Table 101. SMT Next-Generation Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. SMT Main Business
Table 103. SMT Latest Developments
Table 104. Terumo Basic Information, Next-Generation Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 105. Terumo Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
Table 106. Terumo Next-Generation Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Terumo Main Business
Table 108. Terumo Latest Developments
Table 1. Next-Generation Drug-Eluting Stent Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Next-Generation Drug-Eluting Stent Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Cobalt Chromium
Table 4. Major Players of Stainless Steel
Table 5. Major Players of Others
Table 6. Global Next-Generation Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 7. Global Next-Generation Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Table 8. Global Next-Generation Drug-Eluting Stent Revenue by Type (2019-2024) & ($ million)
Table 9. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2019-2024)
Table 10. Global Next-Generation Drug-Eluting Stent Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Next-Generation Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 12. Global Next-Generation Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Table 13. Global Next-Generation Drug-Eluting Stent Revenue by Application (2019-2024)
Table 14. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2019-2024)
Table 15. Global Next-Generation Drug-Eluting Stent Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Next-Generation Drug-Eluting Stent Sales by Company (2019-2024) & (K Units)
Table 17. Global Next-Generation Drug-Eluting Stent Sales Market Share by Company (2019-2024)
Table 18. Global Next-Generation Drug-Eluting Stent Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Company (2019-2024)
Table 20. Global Next-Generation Drug-Eluting Stent Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Next-Generation Drug-Eluting Stent Producing Area Distribution and Sales Area
Table 22. Players Next-Generation Drug-Eluting Stent Products Offered
Table 23. Next-Generation Drug-Eluting Stent Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Next-Generation Drug-Eluting Stent Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Next-Generation Drug-Eluting Stent Sales Market Share Geographic Region (2019-2024)
Table 28. Global Next-Generation Drug-Eluting Stent Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Next-Generation Drug-Eluting Stent Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Next-Generation Drug-Eluting Stent Sales Market Share by Country/Region (2019-2024)
Table 32. Global Next-Generation Drug-Eluting Stent Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Next-Generation Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 35. Americas Next-Generation Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 36. Americas Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Next-Generation Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 38. Americas Next-Generation Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 39. Americas Next-Generation Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 40. APAC Next-Generation Drug-Eluting Stent Sales by Region (2019-2024) & (K Units)
Table 41. APAC Next-Generation Drug-Eluting Stent Sales Market Share by Region (2019-2024)
Table 42. APAC Next-Generation Drug-Eluting Stent Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Next-Generation Drug-Eluting Stent Revenue Market Share by Region (2019-2024)
Table 44. APAC Next-Generation Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 45. APAC Next-Generation Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 46. Europe Next-Generation Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 47. Europe Next-Generation Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 48. Europe Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Next-Generation Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 50. Europe Next-Generation Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 51. Europe Next-Generation Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Next-Generation Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Next-Generation Drug-Eluting Stent
Table 59. Key Market Challenges & Risks of Next-Generation Drug-Eluting Stent
Table 60. Key Industry Trends of Next-Generation Drug-Eluting Stent
Table 61. Next-Generation Drug-Eluting Stent Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Next-Generation Drug-Eluting Stent Distributors List
Table 64. Next-Generation Drug-Eluting Stent Customer List
Table 65. Global Next-Generation Drug-Eluting Stent Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Next-Generation Drug-Eluting Stent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Next-Generation Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Next-Generation Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Next-Generation Drug-Eluting Stent Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Next-Generation Drug-Eluting Stent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Next-Generation Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Next-Generation Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Next-Generation Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Next-Generation Drug-Eluting Stent Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Next-Generation Drug-Eluting Stent Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Next-Generation Drug-Eluting Stent Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Next-Generation Drug-Eluting Stent Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Abbott Basic Information, Next-Generation Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 80. Abbott Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
Table 81. Abbott Next-Generation Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Abbott Main Business
Table 83. Abbott Latest Developments
Table 84. Biosensors International Basic Information, Next-Generation Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 85. Biosensors International Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
Table 86. Biosensors International Next-Generation Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Biosensors International Main Business
Table 88. Biosensors International Latest Developments
Table 89. Medtronic Basic Information, Next-Generation Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 90. Medtronic Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
Table 91. Medtronic Next-Generation Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Medtronic Main Business
Table 93. Medtronic Latest Developments
Table 94. Sorin Group Basic Information, Next-Generation Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 95. Sorin Group Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
Table 96. Sorin Group Next-Generation Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Sorin Group Main Business
Table 98. Sorin Group Latest Developments
Table 99. SMT Basic Information, Next-Generation Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 100. SMT Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
Table 101. SMT Next-Generation Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. SMT Main Business
Table 103. SMT Latest Developments
Table 104. Terumo Basic Information, Next-Generation Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 105. Terumo Next-Generation Drug-Eluting Stent Product Portfolios and Specifications
Table 106. Terumo Next-Generation Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Terumo Main Business
Table 108. Terumo Latest Developments
LIST OF FIGURES
Figure 1. Picture of Next-Generation Drug-Eluting Stent
Figure 2. Next-Generation Drug-Eluting Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Next-Generation Drug-Eluting Stent Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Next-Generation Drug-Eluting Stent Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Next-Generation Drug-Eluting Stent Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Cobalt Chromium
Figure 10. Product Picture of Stainless Steel
Figure 11. Product Picture of Others
Figure 12. Global Next-Generation Drug-Eluting Stent Sales Market Share by Type in 2023
Figure 13. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2019-2024)
Figure 14. Next-Generation Drug-Eluting Stent Consumed in Hospitals
Figure 15. Global Next-Generation Drug-Eluting Stent Market: Hospitals (2019-2024) & (K Units)
Figure 16. Next-Generation Drug-Eluting Stent Consumed in Clinics
Figure 17. Global Next-Generation Drug-Eluting Stent Market: Clinics (2019-2024) & (K Units)
Figure 18. Next-Generation Drug-Eluting Stent Consumed in Ambulatory Surgical Centers
Figure 19. Global Next-Generation Drug-Eluting Stent Market: Ambulatory Surgical Centers (2019-2024) & (K Units)
Figure 20. Global Next-Generation Drug-Eluting Stent Sales Market Share by Application (2023)
Figure 21. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Application in 2023
Figure 22. Next-Generation Drug-Eluting Stent Sales Market by Company in 2023 (K Units)
Figure 23. Global Next-Generation Drug-Eluting Stent Sales Market Share by Company in 2023
Figure 24. Next-Generation Drug-Eluting Stent Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Company in 2023
Figure 26. Global Next-Generation Drug-Eluting Stent Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Next-Generation Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 29. Americas Next-Generation Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 30. APAC Next-Generation Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 31. APAC Next-Generation Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 32. Europe Next-Generation Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 33. Europe Next-Generation Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Next-Generation Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 36. Americas Next-Generation Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 37. Americas Next-Generation Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 38. Americas Next-Generation Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 39. Americas Next-Generation Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 40. United States Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Next-Generation Drug-Eluting Stent Sales Market Share by Region in 2023
Figure 45. APAC Next-Generation Drug-Eluting Stent Revenue Market Share by Regions in 2023
Figure 46. APAC Next-Generation Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 47. APAC Next-Generation Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 48. China Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Next-Generation Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 56. Europe Next-Generation Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 57. Europe Next-Generation Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 58. Europe Next-Generation Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 59. Germany Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Next-Generation Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Next-Generation Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Next-Generation Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 68. Egypt Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Next-Generation Drug-Eluting Stent in 2023
Figure 74. Manufacturing Process Analysis of Next-Generation Drug-Eluting Stent
Figure 75. Industry Chain Structure of Next-Generation Drug-Eluting Stent
Figure 76. Channels of Distribution
Figure 77. Global Next-Generation Drug-Eluting Stent Sales Market Forecast by Region (2025-2030)
Figure 78. Global Next-Generation Drug-Eluting Stent Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Next-Generation Drug-Eluting Stent Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Next-Generation Drug-Eluting Stent Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Next-Generation Drug-Eluting Stent Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Next-Generation Drug-Eluting Stent Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Next-Generation Drug-Eluting Stent
Figure 2. Next-Generation Drug-Eluting Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Next-Generation Drug-Eluting Stent Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Next-Generation Drug-Eluting Stent Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Next-Generation Drug-Eluting Stent Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Cobalt Chromium
Figure 10. Product Picture of Stainless Steel
Figure 11. Product Picture of Others
Figure 12. Global Next-Generation Drug-Eluting Stent Sales Market Share by Type in 2023
Figure 13. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2019-2024)
Figure 14. Next-Generation Drug-Eluting Stent Consumed in Hospitals
Figure 15. Global Next-Generation Drug-Eluting Stent Market: Hospitals (2019-2024) & (K Units)
Figure 16. Next-Generation Drug-Eluting Stent Consumed in Clinics
Figure 17. Global Next-Generation Drug-Eluting Stent Market: Clinics (2019-2024) & (K Units)
Figure 18. Next-Generation Drug-Eluting Stent Consumed in Ambulatory Surgical Centers
Figure 19. Global Next-Generation Drug-Eluting Stent Market: Ambulatory Surgical Centers (2019-2024) & (K Units)
Figure 20. Global Next-Generation Drug-Eluting Stent Sales Market Share by Application (2023)
Figure 21. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Application in 2023
Figure 22. Next-Generation Drug-Eluting Stent Sales Market by Company in 2023 (K Units)
Figure 23. Global Next-Generation Drug-Eluting Stent Sales Market Share by Company in 2023
Figure 24. Next-Generation Drug-Eluting Stent Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Company in 2023
Figure 26. Global Next-Generation Drug-Eluting Stent Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Next-Generation Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 29. Americas Next-Generation Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 30. APAC Next-Generation Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 31. APAC Next-Generation Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 32. Europe Next-Generation Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 33. Europe Next-Generation Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Next-Generation Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 36. Americas Next-Generation Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 37. Americas Next-Generation Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 38. Americas Next-Generation Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 39. Americas Next-Generation Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 40. United States Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Next-Generation Drug-Eluting Stent Sales Market Share by Region in 2023
Figure 45. APAC Next-Generation Drug-Eluting Stent Revenue Market Share by Regions in 2023
Figure 46. APAC Next-Generation Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 47. APAC Next-Generation Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 48. China Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Next-Generation Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 56. Europe Next-Generation Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 57. Europe Next-Generation Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 58. Europe Next-Generation Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 59. Germany Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Next-Generation Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Next-Generation Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Next-Generation Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 68. Egypt Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Next-Generation Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Next-Generation Drug-Eluting Stent in 2023
Figure 74. Manufacturing Process Analysis of Next-Generation Drug-Eluting Stent
Figure 75. Industry Chain Structure of Next-Generation Drug-Eluting Stent
Figure 76. Channels of Distribution
Figure 77. Global Next-Generation Drug-Eluting Stent Sales Market Forecast by Region (2025-2030)
Figure 78. Global Next-Generation Drug-Eluting Stent Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Next-Generation Drug-Eluting Stent Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Next-Generation Drug-Eluting Stent Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Next-Generation Drug-Eluting Stent Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Next-Generation Drug-Eluting Stent Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Companion Animal Medicinal Feed Additives Market Growth 2025-2031
US$ 3,660.00
December 2025
92 pages
Global Nerve Stimulator Market Growth 2025-2031
US$ 3,660.00
January 2025
97 pages
Global Thoracic Stent Graft Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
86 pages
Global Chemotherapy-Induced Myelosuppression Treatments Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
75 pages
Global In-Vitro Colorectal Cancer Screening Tests Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
January 2025
91 pages
